|
Volumn 156, Issue 2, 2012, Pages
|
Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLIBENCLAMIDE;
GLICLAZIDE;
GLIMEPIRIDE;
GLIPIZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
METFORMIN;
NITRATE;
REPAGLINIDE;
TOLBUTAMIDE;
ADULT;
AGED;
CARDIOVASCULAR DISEASE;
COHORT ANALYSIS;
COMORBIDITY;
DENMARK;
FEMALE;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
INSULIN RELEASE;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRESCRIPTION;
PRIORITY JOURNAL;
STROKE;
|
EID: 84855827857
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (0)
|